Serum Institute's move puts India at the forefront of TB vaccine research after a hundred-year gap. If the candidate clears trials, it could mean cheaper, locally made protection for millions. Honestly, it's a proud moment for Indian pharma.
Join the thread
Discussion
Sign in to join the discussion.